The FDA has approved the at-home use of AstraZeneca's FluMist nasal spray vaccine. A prescription will still be required. The vaccines will be available from an on-line pharmacy next fall.
Next year’s flu season will have an additional option for people looking to protect themselves: a flu vaccine that can be ...
Next year’s flu season will have an additional option for people looking to protect themselves: a flu vaccine that can be ...
The EMA CHMP has recommended granting approval for AstraZeneca’s Fasenra for eosinophilic granulomatosis with polyangiitis ...
FluMist has been sold at pharmacies for years, but now it will be available to use at home as early as next year.
There’s good news for those who are short on time when it comes to getting a flu shot. The FDA has approved the first ...
FluMist won't be available until next year, according to the website for FluMist, which is owned by AstraZeneca. Once it does ...
The Food and Drug Administration (FDA) has approved a nasal spray flu vaccine, FluMist, that consumers aged 2 to 49  will be ...
The nasal spray, called FluMist, doesn't require a doctor and can be used for self-administration or by a caregiver. Vaccines ...
The U.S. Food and Drug Administration has approved FluMist — the nasal spray flu vaccine — for home use by a patient or adult caregiver. Dr. Nicole Saphier and Dr. Marc Siegel weigh in.
FluMist, a nasal spray vaccine, can be self-administered and is approved for two-year-olds up to 49-year-olds. It has to be ...
The FDA has approved FluMist (AstraZeneca) for self-administration by adults up to age 49 years or for caregiver administration for children aged 2 to 17 years, making it the first self-administered ...